Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DB23FG61Z
Awardee
Awarding agency
Obligated
$12,934

Award facts

Contract value 100% obligated
$12,934.05 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. under an indefinite-delivery/indefinite-quantity contract vehicle. The order is for 120 capsules of XTANDI 40 MG CAPSULE at a firm fixed price of $12,934.05. Performance will take place in Park Ridge, Illinois with completion by March 23, 2023. No set-aside provision was applied to this order. The DLA supports military readiness by procuring and providing medical supplies and pharmaceuticals to armed services members, indicating the capsules will be used to support patient care within the military health system.

Quick answers

Who was awarded contract SPE2DB23FG61Z?

SPE2DB23FG61Z was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 22, 2023.

How much is contract SPE2DB23FG61Z worth?

The government has obligated $12,934 on SPE2DB23FG61Z.

Is contract SPE2DB23FG61Z an order under another contract?

Yes. SPE2DB23FG61Z is a delivery order under SPE2DB20D9157, an indefinite delivery contract.

Was contract SPE2DB23FG61Z competed?

The extent of competition for SPE2DB23FG61Z was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award